Medicine and Dentistry
Nephropathy
60%
Randomized Controlled Trial
60%
Nephrology
45%
Diseases
37%
Chronic Kidney Disease
35%
Peritoneal Dialysis
30%
Infection
30%
Breast Radiotherapy
30%
Outpatient
30%
Hormone Therapy
30%
Rituximab
30%
Quadrantectomy
30%
Maturity Onset Diabetes of the Young
30%
Patient with Type 2 Diabetes
30%
Glycemic Control
30%
Breast Cancer
30%
Peer Group
30%
Cardiovascular Risk
30%
Hypervolemia
30%
Diabetes
30%
Pre-Eclampsia
30%
Colorectal Carcinoma
30%
Glutamine
30%
Aortic Stenosis
30%
Percutaneous Aortic Valve Replacement
30%
Gestational Diabetes
30%
Risk Perception
30%
Cardiovascular Disease
25%
Prevalence
24%
Health Care Cost
22%
Nephrologist
15%
Decision Making
15%
Diabetes Mellitus
15%
Puerperium
15%
Non Communicable Disease
15%
Attitude
15%
Personal Experience
15%
Creatinine
14%
Congestive Heart Failure
12%
General Practitioner
12%
Awareness
10%
Hazard Ratio
8%
Disease Free Survival
8%
Recurrent Disease
8%
Local Recurrence Free Survival
8%
Myocardial Disease
8%
Quality of Life
8%
Combination Therapy
7%
Patient Compliance
7%
Cardiovascular Disease Risk Factor
7%
Pharmacology, Toxicology and Pharmaceutical Science
Peritoneal Dialysis Fluid
100%
Peritoneal Dialysis Fluid
90%
Meropenem
90%
Fosfomycin
60%
Linezolid
60%
Pharmacokinetics
60%
Dialysis Fluid
43%
Glutamine
30%
Lipegfilgrastim
30%
Staphylococcus Epidermidis
30%
Daptomycin
30%
Recombinant Erythropoietin
30%
Pure Red Cell Anemia
30%
Cefepime
30%
Aztreonam
30%
Ertapenem
30%
Tobramycin
30%
Rituximab
30%
Ampicillin
30%
Enterococcus faecalis
30%
Ciprofloxacin
30%
Peritonitis
28%
Antimicrobial Agent
27%
Minimum Inhibitory Concentration
21%
High Performance Liquid Chromatography
15%
Neutropenia
15%
Infectious Agent
12%
Icodextrin
12%
Urinary Tract Cancer
10%
Granulocyte Colony Stimulating Factor
10%
Febrile Neutropenia
10%
Tumor Antigen
7%
Deionized Water
7%
Antibiotics
6%
Drug Concentration
5%
Bone Pain
5%
Fever
5%
Immunology and Microbiology
Peritoneal Dialysis
90%
Liquid
52%
Solution and Solubility
30%
Lipegfilgrastim
30%
Staphylococcus Epidermidis
30%
Rituximab
30%
Antimicrobial Agent
24%
Antimicrobial Activity
15%
Maximum Concentration
15%
High Performance Liquid Chromatography-Mass Spectrometry
15%
Disk Diffusion
13%
High Performance Liquid Chromatography
13%
Drug Adsorption
11%
Peritonitis
9%
Glucocorticoid
8%
Room Temperature
7%
Drug Concentration
7%
Drug Degradation
6%
Warming
6%
Escherichia coli
6%
Pseudomonas aeruginosa
6%
